Insider Trading March 7, 2026

22NW Fund Reduces Stake in L.B. Foster, Sells $163,906 of Shares

Block of 5,124 shares sold near 52-week high as company posts mixed Q4 2025 results

By Nina Shah FSTR
22NW Fund Reduces Stake in L.B. Foster, Sells $163,906 of Shares
FSTR

22NW Fund, LP and affiliated entities disposed of 5,124 shares of L.B. Foster Company (NASDAQ: FSTR) common stock on March 4, 2026, generating $163,906 in proceeds. The sale took place close to the stock's 52-week peak, while the company reported fourth-quarter 2025 results that beat revenue expectations but missed earnings per share forecasts by a wide margin.

Key Points

  • 22NW Fund, LP and affiliated entities sold 5,124 shares of L.B. Foster (FSTR) on March 4, 2026, at $31.50 to $32.125, totaling $163,906.
  • The sale occurred near FSTR's 52-week high of $32.63; the stock was trading at $28.93 thereafter, with InvestingPro's Fair Value analysis suggesting potential undervaluation.
  • L.B. Foster reported Q4 2025 EPS of $0.22 versus an expected $0.66 (a 66.67% miss), while revenue of $160.4 million exceeded the $157.89 million projection by 1.57%.

An entity affiliated with 22NW Fund, LP — including 22NW, LP — sold 5,124 shares of L.B. Foster Company common stock (NASDAQ: FSTR) on March 4, 2026. The transaction executed at prices between $31.50 and $32.125, producing total proceeds of $163,906.

According to InvestingPro data cited in the filing, the divestiture occurred close to FSTR's 52-week high of $32.63. Since that high-water mark the shares have declined to $28.93, a level InvestingPro's Fair Value analysis indicates may represent undervaluation relative to the service's metric.

The regulatory filing identifies Aron R. English along with 22NW GP, Inc. and 22NW Fund GP, LLC as parties who may be deemed to beneficially own the securities. After the March 4 sale, 22NW Fund, LP directly holds 1,185,922 shares of L.B. Foster common stock; the filing also records a separate direct ownership of 905 shares by 22NW Fund, LP.

InvestingPro subscribers are noted to have access to six additional tips related to FSTR's financials and valuation, as listed in the filing summary.


Financial results released for L.B. Foster's fourth quarter of 2025 show a mixed operating picture. The company reported earnings per share of $0.22, below the expectation of $0.66 and representing a shortfall of 66.67% versus the forecast. Revenue for the quarter came in at $160.4 million, exceeding the projected $157.89 million by 1.57%.

Those outcomes underline a divergence between top-line strength and bottom-line performance for the period. Revenue outperformance may be viewed positively by investors focused on sales momentum, while the marked EPS miss may prompt questions about margins, costs, or other drivers suppressing profitability during the quarter.

Stakeholders - including institutional holders and shareholders tracking insider activity - will likely monitor subsequent disclosures and operating updates as they reassess the company's near-term trajectory and valuation metrics.

No additional details about the motivations behind the 22NW-related sale were included in the filing, and the company has not been reported to have provided commentary tied to the transaction in the materials referenced.

Risks

  • Earnings shortfall - The substantial EPS miss in Q4 2025 could heighten scrutiny of profitability and margin dynamics for the company, affecting investor sentiment in the industrials and materials sectors.
  • Insider selling - The sale by 22NW-related entities, though a defined amount, introduces uncertainty about insider disposition timing and whether additional sales may follow, which can influence market perception in the equity markets.
  • Valuation ambiguity - Despite a revenue beat, the divergence between sales and EPS performance creates uncertainty around fair valuation, complicating assessments by investors and analysts focused on fundamentals.

More from Insider Trading

Lamar Advertising CFO Disposes $173,325 in Stock Ahead of Quarter-End Mar 7, 2026 PepGen CEO Sells 5,275 Shares to Cover Tax Withholding; Market Reacts to Clinical Hold Mar 7, 2026 Five9 EVP Disposes $194,526 of Stock Under 10b5-1 Plan; Company Reports Q4 Beat and CEO Transition Mar 7, 2026 Motorola Solutions CEO Disposes $13.5M in Stock, Exercises Options for Equivalent Shares Mar 7, 2026 Orthofix CP&BOO Vitale Lucas Sells 2,312 Shares to Cover RSU Taxes Mar 7, 2026